Evidence mapPaperPMID 39266748Full record

ArticleNature medicine2024

An open-source framework for end-to-end analysis of electronic health record data.

Lukas Heumos, Philipp Ehmele, Tim Treis, Julius Upmeier Zu Belzen, Eljas Roellin, Lilly May, Altana Namsaraeva, Nastassya Horlava, Vladimir A Shitov, Xinyue Zhang and 11 more

Abstract read
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Lukas HeumosInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.
Philipp EhmeleInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.
Tim TreisInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.
Julius Upmeier Zu BelzenHealth Data Science Unit, Heidelberg University and BioQuant, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-0966-4458
Eljas RoellinInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.
Lilly MayInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.
Altana NamsaraevaInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.
Nastassya HorlavaInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.
Vladimir A ShitovInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-1960-8812
Xinyue ZhangInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-4806-4049
Luke ZappiaInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-7744-8565
Rainer KnollSystems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.
Niklas J LangInstitute of Lung Health and Immunity and Comprehensive Pneumology Center with the CPC-M bioArchive; Helmholtz Zentrum Munich; member of the German Center for Lung Research (DZL), Munich, Germany.
Leon HetzelInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.
Isaac VirshupInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.
Lisa SikkemaInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-9686-6295
Fabiola CurionInstitute of Computational Biology, Helmholtz Munich, Munich, Germany.
Roland EilsHealth Data Science Unit, Heidelberg University and BioQuant, Heidelberg, Germany.
Herbert B SchillerInstitute of Lung Health and Immunity and Comprehensive Pneumology Center with the CPC-M bioArchive; Helmholtz Zentrum Munich; member of the German Center for Lung Research (DZL), Munich, Germany.
Anne HilgendorffInstitute of Lung Health and Immunity and Comprehensive Pneumology Center with the CPC-M bioArchive; Helmholtz Zentrum Munich; member of the German Center for Lung Research (DZL), Munich, Germany.
Fabian J TheisInstitute of Computational Biology, Helmholtz Munich, Munich, Germany. fabian.theis@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0002-2419-1943

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With progressive digitalization of healthcare systems worldwide, large-scale collection of electronic health records (EHRs) has become commonplace. However, an extensible framework for comprehensive exploratory analysis that accounts for data heterogeneity is missing. Here we introduce ehrapy, a modular open-source Python framework designed for exploratory analysis of heterogeneous epidemiology and EHR data. ehrapy incorporates a series of analytical steps, from data extraction and quality control to the generation of low-dimensional representations. Complemented by rich statistical modules, ehrapy facilitates associating patients with disease states, differential comparison between patient clusters, survival analysis, trajectory inference, causal inference and more. Leveraging ontologies, ehrapy further enables data sharing and training EHR deep learning models, paving the way for foundational models in biomedical research. We demonstrate ehrapy's features in six distinct examples. We applied ehrapy to stratify patients affected by unspecified pneumonia into finer-grained phenotypes. Furthermore, we reveal biomarkers for significant differences in survival among these groups. Additionally, we quantify medication-class effects of pneumonia medications on length of stay. We further leveraged ehrapy to analyze cardiovascular risks across different data modalities. We reconstructed disease state trajectories in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on imaging data. Finally, we conducted a case study to demonstrate how ehrapy can detect and mitigate biases in EHR data. ehrapy, thus, provides a framework that we envision will standardize analysis pipelines on EHR data and serve as a cornerstone for the community.

Indexed as

COVID-19Electronic Health RecordsDeep LearningHumansPneumoniaSARS-CoV-2

Identifiers

PMID39266748
PMCPMC11564094

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.